190 related articles for article (PubMed ID: 35430336)
21. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer.
Hatami E; Nagesh PKB; Jaggi M; Chauhan SC; Yallapu MM
Eur J Pharmacol; 2020 Dec; 888():173486. PubMed ID: 32805254
[TBL] [Abstract][Full Text] [Related]
22. One-step preparation of reduction-responsive cross-linked gemcitabine prodrug micelles for intracellular drug delivery.
Chen X; Teng W; Jin Q; Ji J
Colloids Surf B Biointerfaces; 2019 Sep; 181():94-101. PubMed ID: 31125923
[TBL] [Abstract][Full Text] [Related]
23. 4-Carboxyphenylboronic acid-decorated, redox-sensitive rod-shaped nano-micelles fabricated through co-assembling strategy for active targeting and synergistic co-delivery of camptothecin and gemcitabine.
Xu Y; Huang Y; Lu W; Liu S; Xiao Y; Yu J
Eur J Pharm Biopharm; 2019 Nov; 144():193-206. PubMed ID: 31560954
[TBL] [Abstract][Full Text] [Related]
24. EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer.
Mondal G; Almawash S; Chaudhary AK; Mahato RI
Mol Pharm; 2017 Sep; 14(9):3121-3133. PubMed ID: 28719220
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties.
Hong S; Fang Z; Jung HY; Yoon JH; Hong SS; Maeng HJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314360
[TBL] [Abstract][Full Text] [Related]
26. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
Zhang R; Ru Y; Gao Y; Li J; Mao S
Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells.
Han NK; Shin DH; Kim JS; Weon KY; Jang CY; Kim JS
Int J Nanomedicine; 2016; 11():1413-25. PubMed ID: 27103799
[TBL] [Abstract][Full Text] [Related]
28. An Amphiphilic PEGylated Peptide Dendron-Gemcitabine Prodrug-Based Nanoagent for Cancer Therapy.
Li N; Duan Z; Wang L; Guo C; Zhang H; Gu Z; Gong Q; Luo K
Macromol Rapid Commun; 2021 Jun; 42(12):e2100111. PubMed ID: 33871122
[TBL] [Abstract][Full Text] [Related]
29. Redox-responsive self-assembled polymeric nanoprodrug for delivery of gemcitabine in B-cell lymphoma therapy.
Zhong W; Zhang X; Duan X; Liu H; Fang Y; Luo M; Fang Z; Miao C; Lin D; Wu J
Acta Biomater; 2022 May; 144():67-80. PubMed ID: 35331940
[TBL] [Abstract][Full Text] [Related]
30. Molecularly targeted gemcitabine-loaded nanoparticulate system towards the treatment of EGFR overexpressing lung cancer.
Wang XB; Zhou HY
Biomed Pharmacother; 2015 Mar; 70():123-8. PubMed ID: 25776490
[TBL] [Abstract][Full Text] [Related]
31. EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer.
Mondal G; Kumar V; Shukla SK; Singh PK; Mahato RI
Biomacromolecules; 2016 Jan; 17(1):301-13. PubMed ID: 26626700
[TBL] [Abstract][Full Text] [Related]
32. Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer.
Noh I; Kim HO; Choi J; Choi Y; Lee DK; Huh YM; Haam S
Biomaterials; 2015; 53():763-74. PubMed ID: 25890771
[TBL] [Abstract][Full Text] [Related]
33. Enhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivo.
Tao XM; Wang JC; Wang JB; Feng Q; Gao SY; Zhang LR; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):401-9. PubMed ID: 22728546
[TBL] [Abstract][Full Text] [Related]
34. Codelivery of dual drugs from polymeric micelles for simultaneous targeting of both cancer cells and cancer stem cells.
Krishnamurthy S; Ng VW; Gao S; Tan MH; Hedrick JL; Yang YY
Nanomedicine (Lond); 2015; 10(18):2819-32. PubMed ID: 26377155
[TBL] [Abstract][Full Text] [Related]
35. A NAG-Guided Nano-Delivery System for Redox- and pH-Triggered Intracellularly Sequential Drug Release in Cancer Cells.
Liang Y; Zhang J; Tian B; Wu Z; Svirskis D; Han J
Int J Nanomedicine; 2020; 15():841-855. PubMed ID: 32103941
[TBL] [Abstract][Full Text] [Related]
36. A biocompatible and cathepsin B sensitive nanoscale system of dendritic polyHPMA-gemcitabine prodrug enhances antitumor activity markedly.
Dai Y; Ma X; Zhang Y; Chen K; Tang JZ; Gong Q; Luo K
Biomater Sci; 2018 Nov; 6(11):2976-2986. PubMed ID: 30255871
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic Acid-Modified Micelles Encapsulating Gem-C
Liu X; Li W; Chen T; Yang Q; Huang T; Fu Y; Gong T; Zhang Z
Mol Pharm; 2018 Mar; 15(3):1203-1214. PubMed ID: 29397747
[TBL] [Abstract][Full Text] [Related]
38. Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy.
Zhang C; Pan D; Li J; Hu J; Bains A; Guys N; Zhu H; Li X; Luo K; Gong Q; Gu Z
Acta Biomater; 2017 Jun; 55():153-162. PubMed ID: 28259838
[TBL] [Abstract][Full Text] [Related]
39. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.
Youngren-Ortiz SR; Hill DB; Hoffmann PR; Morris KR; Barrett EG; Forest MG; Chougule MB
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):299-321. PubMed ID: 28277892
[TBL] [Abstract][Full Text] [Related]
40. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
